Glaucoma
USMLE Step 1 trap: Attributes the acute painful presentation of angle-closure glaucoma to open-angle glaucoma. Open-angle glaucoma is painless and insidious, causing gradual peripheral visual field loss; acute pain and halos are features of angle-closure glaucoma.
Glaucoma is a group of conditions that damage the optic nerve, typically through elevated intraocular pressure (IOP), and it's one of the highest-yield ophthalmology topics on USMLE Step 1. The exam splits this into two fundamentally different diseases — open-angle and closed-angle — and tests whether you understand the distinct mechanisms, presentations, and drug choices for each. You need to know the aqueous humor drainage pathway (ciliary body → posterior chamber → pupil → anterior chamber → trabecular meshwork → Schlemm canal) cold, because every drug class makes sense once you understand where it intervenes.
The trickiest part is that students conflate the two types based on symptoms they half-remember. Open-angle glaucoma is the silent killer — painless, slowly progressive peripheral vision loss, often discovered incidentally. Closed-angle is the dramatic emergency — sudden severe eye pain, headache, nausea, blurred vision, halos around lights, and a fixed mid-dilated pupil. USMLE Step 1 will give you a clinical vignette and expect you to sort these correctly before you even get to drug selection. The other major trap is drug mechanism: timolol (beta-blocker) decreases aqueous production, latanoprost (prostaglandin analog) increases uveoscleral outflow, and pilocarpine (muscarinic agonist) constricts the pupil to mechanically open the trabecular meshwork — and it's first-line in angle-closure emergencies specifically.
The misconceptions here are specific and predictable. Students frequently assign the acute painful presentation to open-angle glaucoma, and they misidentify the trigger for angle-closure as bright light rather than pupillary dilation. Getting these backwards will cost you points on questions that are otherwise straightforward. On USMLE Step 1, the glaucoma question often embeds the diagnosis in a passage about a patient given anticholinergic medication or brought into a dark room — you have to recognize that pupillary dilation is the physiologic trigger for angle-closure, not light itself.
Common misconceptions
What the exam tests
- Know the pathophysiology of open-angle glaucoma — impaired aqueous drainage through the trabecular meshwork leading to gradual IOP elevation — and which drug classes target which steps in aqueous production or outflow (beta-blockers, prostaglandin analogs, carbonic anhydrase inhibitors, alpha-2 agonists, miotics).
- Recognize the acute angle-closure presentation: sudden severe eye pain, headache, nausea/vomiting, blurred vision with halos, a fixed mid-dilated pupil, and a rock-hard eye — and identify the correct emergent management (pilocarpine, acetazolamide, timolol, then laser iridotomy).
- Identify the triggers for acute angle-closure glaucoma, particularly pupillary dilation from dim lighting, mydriatic drops, or anticholinergic/sympathomimetic drugs — and understand why dilation narrows the iridocorneal angle in anatomically predisposed patients.
- Distinguish the clinical course: open-angle causes painless, insidious peripheral (tunnel) vision loss with optic disc cupping and elevated cup-to-disc ratio, whereas closed-angle is an acute emergency requiring prompt intervention to prevent permanent vision loss.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →